WNT4 and neoplasm: Findings of these experiments suggest that SIRT6 by targeting the inhibitor WNT4 might modulate insulin secretion from pancreatic β‐cells and thereby probably curtail muscle atrophy associated with tumour growth in Tu‐Sk.T6Tg mice.